BUFFALO, NY - Roswell Park Cancer Institute (RPCI) has appointed three new faculty members to the Department of Medicine.
Foluso Olabisi (Bisi) Ademuyiwa, MD, MPH, will see patients in the RPCI Breast Clinic.Dr. Ademuyiwa comes to RPCI from Indiana University School of Medicine, Indianapolis, IN, where she completed a fellowship in Hematology/Oncology. She earned her Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1999 from the University of Ibadan, Nigeria. Dr. Ademuyiwa also earned her Master of Public Health (MPH) in 2001 from the Bloomberg School of Public Health, Johns Hopkins University. She completed a combined residency training program in 2006 in the Division of Internal Medicine/Pediatrics, Bridgeport Hospital, Yale New Haven Health, CT.
Dr. Ademuyiwa is board-certified in Internal Medicine and General Pediatrics. She is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Her research interests focus on racial disparities in breast cancer, identifying novel therapies for triple negative breast cancer and molecular epidemiology.
Hongbin Chen, MD PhD, will treat Roswell Park patients diagnosed with lung cancer. Dr. Chen comes to RPCI from The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University where he completed a fellowship in medical oncology. He earned his medical degree in 1992 at the Shanghai Medical University, Shanghai, China and his doctoral degree in Aging Studies in 2002 from the University of South Florida, Tampa, FL. Dr. Chen completed residency training in Internal Medicine at the University at Buffalo School of Medicine and Biomedical Sciences.
Dr. Chen is certified by the American Board of Internal Medicine. He also is board-certified in medical oncology. He is a member of the American College of Physicians; American Society of Clinical Oncology, American Association for Cancer Research, American Geriatrics Society and the Gerontological Society of America. He will focus his research on translational and clinic trials in thoracic oncology.
Hong Liu, MD PhD, will provide care to Roswell Park patients diagnosed with multiple myeloma and leukemia. Dr. Liu comes to RPCI from the College of Medicine, University of Florida, Gainesville, FL, where she completed residency training in Internal Medicine and a fellowship in Hematology/Oncology. She earned her medical degree from the Beijing Medical University, and her doctoral degree in Microbiology and Immunology from the University of Texas Medical Branch.
Dr. Liu is certified by the American Board of Internal Medicine. She is a member of American Society of Hematology, American Society of Clinical Oncology and the American Society for Blood and Marrow Transplantation. Her research interests focus on clinical research of multiple myeloma and leukemia.
The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. RPCI, founded in 1898, was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. For more information, visit RPCI’s website at http://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or email email@example.com.
Annie Deck-Miller, Senior Media Relations Manager